BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14827945)

  • 1. Clinical experiences with the anticoagulant, ethyl biscoumacetate (N.N.R.).
    BARKER NW; ESTES JE; MANN FD
    Proc Staff Meet Mayo Clin; 1951 Apr; 26(9):162-7. PubMed ID: 14827945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic value of a new anticoagulant: the ethyl ester of di-3,3'-(4-oxycoumarinyl) acetic acid].
    LIAN C; SIGUIER F; WELTI JJ; COBLENTZ B; NEDEY ; BREYNAERT
    Sem Hop; 1951 May; 27(35):1511-22. PubMed ID: 14866256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological properties and physiological effects of a new anticoagulant: the ethyl ester of di-3,3'-(4-oxycoumarinyl) acetic acid].
    LIAN C; SIGUIER F; WELTI JJ; PIETTE M; POULLAIN P; PHILIPPON J
    Sem Hop; 1951 May; 27(35):1505-11. PubMed ID: 14866255
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new synthetic anticoagulant, the ethyl ester of dioxycoumarinyl-acetic acid or tromexan].
    BICKEL G; DELLA SANTA R
    Rev Med Suisse Romande; 1949 Sep; 69(9):545-58. PubMed ID: 18140885
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of dicumarinyl derivatives with a metabolic study of the radioactively labeled anticoagulants in animals.
    HAUSNER EP; SHAFER CL; CORSON M; JOHNSON O; TRUJILLO T; LANGHAM W
    Circulation; 1951 Feb; 3(2):171-81. PubMed ID: 14812645
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new synthetic anticoagulant; Tromexan (G 11705)].
    DELLA SANTA R
    Schweiz Med Wochenschr; 1949 Mar; 79(9):195-206. PubMed ID: 18115607
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulant therapy with tromexan].
    GARCIA TURIELLA R; GASPARY FV; TUERO PR; FERRER J
    Prensa Med Argent; 1953 Aug; 40(32):2093-2103. PubMed ID: 13088693
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulant therapy; tromexan and G-23350].
    MAROIS A; BROSSEAU C
    Laval Med; 1955 Sep; 20(7):940-51. PubMed ID: 13279212
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with the anticoagulant, tromexan.
    BRONSTEIN MR; WITKIND E
    Am J Med Sci; 1951 Dec; 222(6):677-85. PubMed ID: 14885211
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical results with tromexan, a new anticoagulant].
    von KAULLA KN
    Dtsch Med Wochenschr; 1950 Sep; 75(38):1259-62. PubMed ID: 14773354
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials with a new anticoagulant; tromexan].
    MILANES B; HERNANDEZ A; PEREZ STABLE E
    Rev Cubana Cardiol; 1951; 12(4):141-50. PubMed ID: 12994207
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON BLOOD COAGULATION CHANGES AND THE ANTICOAGULANT EFFECT OF MONOAMINE OXIDASE INHIBITORS].
    HRDINA P; KOVALCIK V
    Cas Lek Cesk; 1963 May; 102():574-9. PubMed ID: 14051515
    [No Abstract]   [Full Text] [Related]  

  • 15. A study on the toxicology and anticoagulant action of tromexan, a synthetic coumarin.
    GRUBER CM; LEE KS; LASZICZENKO T; GRUBER CM
    Arch Int Pharmacodyn Ther; 1951 Sep; 87(4):402-12. PubMed ID: 14895202
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with thrombocid, dicumarol and tromexan in the prophylaxis and treatment of thrombosis and embolism].
    BRETTLER A; HOEPFNER W
    Z Urol; 1951; 44(7):464-79. PubMed ID: 14867571
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new anticoagulant, tromexan; its action in health and disease and the interference of other medicinals].
    AVELLANEDA M; CASTRO CM; STRITZLER G
    Cardiologia (Basel); 1953; 22(6):321-32. PubMed ID: 13082497
    [No Abstract]   [Full Text] [Related]  

  • 18. The coagulation defect caused by tromexan therapy.
    DOUGLAS AS
    Clin Sci; 1955 Nov; 14(4):601-13. PubMed ID: 13270444
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with Tromexan, a new anticoagulant of the Dicumarol type].
    DEUTSCH E
    Schweiz Med Wochenschr; 1949 Oct; 79(42):1010-5. PubMed ID: 15393257
    [No Abstract]   [Full Text] [Related]  

  • 20. [CHYMORAL AND COAGULATION].
    PESSEREAU G; MONTEIL R
    Rev Int Serv Sante Armees; 1963 Nov; 36():647-59. PubMed ID: 14094765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.